Patent number: 6995272
Abstract: The invention relates to a crystal modification of the compound of the formula I and the processes for the preparation of and use that crystal modifications 1. The invention is used for treating acute immunological episodes, such as sepsis, allergies, graft-versus-host and host-versus-graft-reactions, autoimmune diseases, in particular rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, atopic dermatitis, asthma, urticaria, rhinitis, uveitis, type II diabetes, liver fibrosis, cystic fibrosis, colitis, cancers, such as lung cancer, leukemia, ovarian cancer, sarcomas, Kaposi's sarcoma, meningioma, intestinal cancer, lymphatic cancer, brain tumors, breast cancer, pancreatic cancer, prostate cancer, or skin cancer.
Type:
Grant
Filed:
April 23, 2004
Date of Patent:
February 7, 2006
Assignee:
Sanofi-Aventis Deutschland GmbH
Inventors:
Holger Faasch, Udo Hedtmann, Uwe Westenfelder, Erich Paulus
Patent number: 6900334
Abstract: The invention relates to a crystal modification of the compound of the formula I and the processes for the preparation of and use that crystal modifications 1. The invention is used for treating acute immunological episodes, such as sepsis, allergies, graft-versus-host and host-versus-graft-reactions, autoimmune diseases, in particular rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, atopic dermatitis, asthma, urticaria, rhinitis, uveitis, type II diabetes, liver fibrosis, cystic fibrosis, colitis, cancers, such as lung cancer, leukemia, ovarian cancer, sarcomas, Kaposi's sarcoma, meningioma, intestinal cancer, lymphatic cancer, brain tumors, breast cancer, pancreatic cancer, prostate cancer, or skin cancer.
Type:
Grant
Filed:
November 25, 2002
Date of Patent:
May 31, 2005
Assignee:
Aventis Pharma Deutschland GmbH
Inventors:
Holger Faasch, Udo Hedtmann, Uwe Westenfelder, Erich Paulus
Patent number: 6552202
Abstract: The invention relates to a crystal modification of the compound of the formula I
and the processes for the preparation of and use that crystal modifications 1. The invention is used for treating acute immunological episodes, such as sepsis, allergies, graft-versus-host and host-versus-graft-reactions, autoimmune diseases, in particular rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, atopic dermatitis, asthma, urticaria, rhinitis, uveitis, type 11 diabetes, liver fibrosis, cystic fibrosis, colitis, cancers, such as lung cancer, leukemia, ovarian cancer, sarcomas, Kaposi's sarcoma, meningioma, intestinal cancer, lymphatic cancer, brain tumors, breast cancer, pancreatic cancer, prostate cancer, or skin cancer.
Type:
Grant
Filed:
January 19, 2001
Date of Patent:
April 22, 2003
Assignee:
Aventis Pharma Deutschland GmbH
Inventors:
Holger Faasch, Udo Hedtmann, Uwe Westenfelder, Erich Paulus
Patent number: 6221891
Abstract: The invention relates to a crystal modification of the compound of the formula I
and the processes for the preparation of and use that crystal modifications 1. The invention is used for treating acute immunological episodes, such as sepsis, allergies, graft-versus-host and host-versus-graft-reactions, autoimmune diseases, in particular rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, atopic dermatitis, asthma, urticaria, rhinitis, uveitis, type II diabetes, liver fibrosis, cystic fibrosis, colitis, cancers, such as lung cancer, leukemia, ovarian cancer, sarcomas, Kaposi's sarcoma, meningioma, intestinal cancer, lymphatic cancer, brain tumors, breast cancer, pancreatic cancer, prostate cancer, or skin cancer.
Type:
Grant
Filed:
October 28, 1999
Date of Patent:
April 24, 2001
Assignee:
Aventis Pharma Deutschland GmbH
Inventors:
Holger Faasch, Udo Hedtmann, Uwe Westenfelder, Erich Paulus
Patent number: 6060494
Abstract: The invention relates to a crystal modification of the compound of the formula I ##STR1## and the processes for the preparation of and use that crystal modifications 1. The invention is used for treating acute immunological episodes, such as sepsis, allergies, graft-versus-host and host-versus-graft-reactions, autoimmune diseases, in particular rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, atopic dermatitis, asthma, urticaria, rhinitis, uveitis, type II diabetes, liver fibrosis, cystic fibrosis, colitis, cancers, such as lung cancer, leukemia, ovarian cancer, sarcomas, Kaposi's sarcoma, meningioma, intestinal cancer, lymphatic cancer, brain tumors, breast cancer, pancreatic cancer, prostate cancer, or skin cancer.
Type:
Grant
Filed:
August 6, 1998
Date of Patent:
May 9, 2000
Assignee:
Hoechst Marion Roussel Deutschland GmbH
Inventors:
Holger Faasch, Udo Hedtmann, Uwe Westenfelder, Erich Paulus